Skip to main content

FDA recall, , Moderate risk

STA Staclot Protein S

STA Staclot Protein S has a positive drift in QC values within its stated 4-hour onboard stability period.

What happened

Diagnostica Stago, Inc., of Parsippany, New Jersey, recalled STA Staclot Protein S, a qualitative and quantitative factor deficiency test, after a positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified. The recall began July 29, 2026, and was added to the FDA's Enforcement Report on August 28, 2026. The product was distributed nationwide in the states and territory of NJ, NY, VA, PA, FL, AL, GA, TN, OH, IL, MO, NE, TX, CO, UT, CA, and PR.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the list below, then check the codes the FDA notice also names.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. STA Staclot Protein S

    UDI-DI
    • 3607450007466
    Lot code
    • 273074

From the FDA notice

STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074;

Recall details

Company began the recall
Sold in

US Nationwide distribution in the states and territory of NJ, NY, NJ, VA, PA, FL, AL, GA, TN, OH, IL, MO, NE, TX, CO, UT, CA, PR.

Company
Diagnostica Stago, Inc.Parsippany, New Jersey
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99531
Recall number
Z-3047-2026
Quantity recalled
5220 units

All recalls from Diagnostica Stago, Inc.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)